Benefits and risks of using antidepressants in children and adolescents

The present controversy about the use of selective serotonin re-uptake inhibitors in paediatric patients has been the subject of many publications. This article summarises the available data on the efficacy and safety of selective serotonin re-uptake inhibitors and other non-tricyclic antidepressant...

Full description

Saved in:
Bibliographic Details
Published inExpert opinion on drug safety Vol. 7; no. 1; p. 9
Main Author Bailly, Daniel
Format Journal Article
LanguageEnglish
Published England 01.01.2008
Subjects
Adolescent
Age Factors
Antidepressive Agents - adverse effects
Antidepressive Agents - therapeutic use
Anxiety Disorders - chemically induced
Anxiety Disorders - drug therapy
Anxiety Disorders - psychology
Child
Controlled Clinical Trials as Topic - methods
Humans
Mental Disorders - drug therapy
Mental Disorders - psychology
Risk Factors
Self-Injurious Behavior - chemically induced
Self-Injurious Behavior - drug therapy
Self-Injurious Behavior - psychology
Online AccessGet more information

Cover

More Information
Summary:The present controversy about the use of selective serotonin re-uptake inhibitors in paediatric patients has been the subject of many publications. This article summarises the available data on the efficacy and safety of selective serotonin re-uptake inhibitors and other non-tricyclic antidepressants in children and adolescents with mental disorders. These data are compared with those related to the efficacy and safety of tricyclic antidepressants. If selective serotonin re-uptake inhibitors appear to be the drugs of choice in depressive and anxiety disorders, their effects are strongest in non-obsessive-compulsive anxiety disorders, intermediate in obsessive-compulsive disorders and more modest in major depressive disorders. All antidepressants may induce psychiatric and suicide-related adverse events. In this respect, the balance of benefit and risk seems to favour fluoxetine as the first-choice antidepressant. Above all, this review emphasises research questions that need to be answered fully about the potential role of antidepressants in the management of children and adolescents with psychiatric disorders. Given these unanswered questions, the use of antidepressant medications in children and adolescents should remain cautious and well monitored.
ISSN:1744-764X
DOI:10.1517/14740338.7.1.9